Dorgan Drug Importation Amendment Has White House In Thorny Position
Executive Summary
An amendment being debated on the Senate floor that would allow consumers to import prescription drugs from other countries creates a particularly thorny situation for the White House: while President Obama was a co-sponsor of the measure when he was still a freshman senator, his support of it now would effectively break the $80 billion deal he brokered with the pharmaceutical industry
You may also be interested in...
FDA Drug Safety Approach To Be Questioned At House Hearing
Principal Deputy Commissioner Joshua Sharfstein is scheduled to go before the House Energy and Commerce Health Subcommittee on March 10.
FDA Drug Safety Approach To Be Questioned At House Hearing
Principal Deputy Commissioner Joshua Sharfstein is scheduled to go before the House Energy and Commerce Health Subcommittee on March 10.
PhRMA Deal Remains Intact As Senate Majority Leaders Vote Against Drug Importation
The $80 billion deal the Rx industry struck as part of health care reform lives to see another day as drug importation fails on the Senate floor.